Logo image of ONTEX.BR

ONTEX GROUP NV (ONTEX.BR) Stock Fundamental Analysis

Europe - EBR:ONTEX - BE0974276082 - Common Stock

6.24 EUR
-0.03 (-0.48%)
Last: 9/16/2025, 5:29:52 PM
Fundamental Rating

3

Overall ONTEX gets a fundamental rating of 3 out of 10. We evaluated ONTEX against 13 industry peers in the Personal Care Products industry. ONTEX has a bad profitability rating. Also its financial health evaluation is rather negative. ONTEX has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

ONTEX had positive earnings in the past year.
In the past year ONTEX had a positive cash flow from operations.
In multiple years ONTEX reported negative net income over the last 5 years.
Each year in the past 5 years ONTEX had a positive operating cash flow.
ONTEX.BR Yearly Net Income VS EBIT VS OCF VS FCFONTEX.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

The Return On Assets of ONTEX (0.44%) is worse than 76.92% of its industry peers.
ONTEX has a Return On Equity of 1.11%. This is in the lower half of the industry: ONTEX underperforms 76.92% of its industry peers.
The Return On Invested Capital of ONTEX (6.78%) is worse than 76.92% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ONTEX is significantly below the industry average of 12.42%.
The 3 year average ROIC (4.39%) for ONTEX is below the current ROIC(6.78%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.44%
ROE 1.11%
ROIC 6.78%
ROA(3y)-2.71%
ROA(5y)-1.72%
ROE(3y)-8.84%
ROE(5y)-5.5%
ROIC(3y)4.39%
ROIC(5y)4.43%
ONTEX.BR Yearly ROA, ROE, ROICONTEX.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

ONTEX has a worse Profit Margin (0.55%) than 76.92% of its industry peers.
In the last couple of years the Profit Margin of ONTEX has declined.
ONTEX has a worse Operating Margin (7.98%) than 76.92% of its industry peers.
In the last couple of years the Operating Margin of ONTEX has grown nicely.
ONTEX's Gross Margin of 29.23% is on the low side compared to the rest of the industry. ONTEX is outperformed by 84.62% of its industry peers.
In the last couple of years the Gross Margin of ONTEX has remained more or less at the same level.
Industry RankSector Rank
OM 7.98%
PM (TTM) 0.55%
GM 29.23%
OM growth 3Y8.65%
OM growth 5Y4.46%
PM growth 3YN/A
PM growth 5Y-19.47%
GM growth 3Y0.83%
GM growth 5Y1.47%
ONTEX.BR Yearly Profit, Operating, Gross MarginsONTEX.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ONTEX is creating some value.
The number of shares outstanding for ONTEX remains at a similar level compared to 1 year ago.
ONTEX has more shares outstanding than it did 5 years ago.
ONTEX has a better debt/assets ratio than last year.
ONTEX.BR Yearly Shares OutstandingONTEX.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ONTEX.BR Yearly Total Debt VS Total AssetsONTEX.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

ONTEX has an Altman-Z score of 1.28. This is a bad value and indicates that ONTEX is not financially healthy and even has some risk of bankruptcy.
ONTEX's Altman-Z score of 1.28 is on the low side compared to the rest of the industry. ONTEX is outperformed by 84.62% of its industry peers.
ONTEX has a debt to FCF ratio of 6.97. This is a slightly negative value and a sign of low solvency as ONTEX would need 6.97 years to pay back of all of its debts.
The Debt to FCF ratio of ONTEX (6.97) is worse than 69.23% of its industry peers.
ONTEX has a Debt/Equity ratio of 0.72. This is a neutral value indicating ONTEX is somewhat dependend on debt financing.
ONTEX has a Debt to Equity ratio (0.72) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 6.97
Altman-Z 1.28
ROIC/WACC1.18
WACC5.73%
ONTEX.BR Yearly LT Debt VS Equity VS FCFONTEX.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

ONTEX has a Current Ratio of 1.21. This is a normal value and indicates that ONTEX is financially healthy and should not expect problems in meeting its short term obligations.
ONTEX has a Current ratio of 1.21. This is comparable to the rest of the industry: ONTEX outperforms 53.85% of its industry peers.
ONTEX has a Quick Ratio of 1.21. This is a bad value and indicates that ONTEX is not financially healthy enough and could expect problems in meeting its short term obligations.
ONTEX has a better Quick ratio (0.81) than 61.54% of its industry peers.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.81
ONTEX.BR Yearly Current Assets VS Current LiabilitesONTEX.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

The earnings per share for ONTEX have decreased strongly by -72.09% in the last year.
Measured over the past years, ONTEX shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -23.62% on average per year.
ONTEX shows a small growth in Revenue. In the last year, the Revenue has grown by 3.67%.
The Revenue has been decreasing by -4.00% on average over the past years.
EPS 1Y (TTM)-72.09%
EPS 3YN/A
EPS 5Y-23.62%
EPS Q2Q%-71.21%
Revenue 1Y (TTM)3.67%
Revenue growth 3Y9.72%
Revenue growth 5Y-4%
Sales Q2Q%4.6%

3.2 Future

ONTEX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.94% yearly.
The Revenue is expected to grow by 2.05% on average over the next years.
EPS Next Y-8.38%
EPS Next 2Y2.21%
EPS Next 3Y4.66%
EPS Next 5Y8.94%
Revenue Next Year-0.99%
Revenue Next 2Y0.86%
Revenue Next 3Y1.71%
Revenue Next 5Y2.05%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ONTEX.BR Yearly Revenue VS EstimatesONTEX.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B 2B
ONTEX.BR Yearly EPS VS EstimatesONTEX.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 52.00, the valuation of ONTEX can be described as expensive.
Based on the Price/Earnings ratio, ONTEX is valued more expensive than 84.62% of the companies in the same industry.
ONTEX is valuated expensively when we compare the Price/Earnings ratio to 27.27, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 6.23, the valuation of ONTEX can be described as very cheap.
Based on the Price/Forward Earnings ratio, ONTEX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of ONTEX to the average of the S&P500 Index (22.77), we can say ONTEX is valued rather cheaply.
Industry RankSector Rank
PE 52
Fwd PE 6.23
ONTEX.BR Price Earnings VS Forward Price EarningsONTEX.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ONTEX is valued cheaper than 92.31% of the companies in the same industry.
ONTEX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ONTEX is cheaper than 92.31% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.97
EV/EBITDA 5.3
ONTEX.BR Per share dataONTEX.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.21%
EPS Next 3Y4.66%

0

5. Dividend

5.1 Amount

No dividends for ONTEX!.
Industry RankSector Rank
Dividend Yield N/A

ONTEX GROUP NV

EBR:ONTEX (9/16/2025, 5:29:52 PM)

6.24

-0.03 (-0.48%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)07-31 2025-07-31
Earnings (Next)10-22 2025-10-22
Inst Owners38.76%
Inst Owner ChangeN/A
Ins Owners3.06%
Ins Owner ChangeN/A
Market Cap513.86M
Analysts78.46
Price Target7.96 (27.56%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.23%
PT rev (3m)-26.6%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-17.96%
EPS NY rev (3m)-17.96%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.46%
Revenue NY rev (3m)-4.15%
Valuation
Industry RankSector Rank
PE 52
Fwd PE 6.23
P/S 0.28
P/FCF 4.97
P/OCF 2.38
P/B 0.56
P/tB 5.56
EV/EBITDA 5.3
EPS(TTM)0.12
EY1.92%
EPS(NY)1
Fwd EY16.06%
FCF(TTM)1.25
FCFY20.1%
OCF(TTM)2.62
OCFY41.98%
SpS22.59
BVpS11.24
TBVpS1.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.44%
ROE 1.11%
ROCE 9.14%
ROIC 6.78%
ROICexc 7.02%
ROICexgc 15%
OM 7.98%
PM (TTM) 0.55%
GM 29.23%
FCFM 5.55%
ROA(3y)-2.71%
ROA(5y)-1.72%
ROE(3y)-8.84%
ROE(5y)-5.5%
ROIC(3y)4.39%
ROIC(5y)4.43%
ROICexc(3y)4.61%
ROICexc(5y)4.96%
ROICexgc(3y)9.94%
ROICexgc(5y)12.9%
ROCE(3y)5.92%
ROCE(5y)5.98%
ROICexcg growth 3Y14.1%
ROICexcg growth 5Y2.75%
ROICexc growth 3Y23.18%
ROICexc growth 5Y5.84%
OM growth 3Y8.65%
OM growth 5Y4.46%
PM growth 3YN/A
PM growth 5Y-19.47%
GM growth 3Y0.83%
GM growth 5Y1.47%
F-Score6
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 6.97
Debt/EBITDA 3
Cap/Depr 151.69%
Cap/Sales 6.04%
Interest Coverage 3.95
Cash Conversion 96.9%
Profit Quality 1002.91%
Current Ratio 1.21
Quick Ratio 0.81
Altman-Z 1.28
F-Score6
WACC5.73%
ROIC/WACC1.18
Cap/Depr(3y)125.61%
Cap/Depr(5y)112.58%
Cap/Sales(3y)5.05%
Cap/Sales(5y)4.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72.09%
EPS 3YN/A
EPS 5Y-23.62%
EPS Q2Q%-71.21%
EPS Next Y-8.38%
EPS Next 2Y2.21%
EPS Next 3Y4.66%
EPS Next 5Y8.94%
Revenue 1Y (TTM)3.67%
Revenue growth 3Y9.72%
Revenue growth 5Y-4%
Sales Q2Q%4.6%
Revenue Next Year-0.99%
Revenue Next 2Y0.86%
Revenue Next 3Y1.71%
Revenue Next 5Y2.05%
EBIT growth 1Y43.9%
EBIT growth 3Y19.21%
EBIT growth 5Y0.28%
EBIT Next Year94.21%
EBIT Next 3Y29.88%
EBIT Next 5Y17.55%
FCF growth 1Y61.15%
FCF growth 3Y11.86%
FCF growth 5Y-5.23%
OCF growth 1Y34.31%
OCF growth 3Y18.3%
OCF growth 5Y-2.03%